This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
477 posters, 14 topics, 2,052 authors, 1,056 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
17 - 19 September, 2026 | Porto, Portugal
PP44
Sebastian Simon, Jennyfer A Mitterer, Bernhard JH Frank, Stephanie Huber, Sujeesh Sebastian, Susana Gardete-Hartmann, Jochen G Hofstaetter
Orthopaedic Hospital Vienna Speising, Vienna, Austria; University hospital basel, Basel, Switzerland, Orthopaedic Hospital Vienna Speising, Vienna, Austria
Prosthetic Joint Infections
Introduction: The direct-anterior-approach (DAA) used in primary total-hip-arthroplasty (THA) is gaining popularity and has infection rates comparable to other surgical approaches. While 2-stage revision remains the gold-standard for chronic periprosthetic-joint-infection (PJI), little data exist on the DAA. This study evaluated reinfection, and complication-rates of two-stage septic revisions performed using the DAA.
Methods: This retrospective single-center study included data from 8,476 patients who underwent primary THA using the DAA between 2013-2024. All patients who underwent a 2-stage procedure for chronic-PJI were included. Clinical outcomes, complication-rates, and microbiological spectrum were assessed. All patients received an antibiotic-loaded cement spacer at 1st-stage, followed by antimicrobial therapy.
Results: We identified 36/8,476 (0.4%) patients (Female:41.7%, Male:58.3%) who underwent septic 2-stage revision after primary DAA-THA. Infection-free survival was 83.4% at a median 6.2-year follow-up. Successful 2nd-stage reimplantation occurred in 28/36 patients (77.8%), while 2/36 (5.6%) remained infection-free after a 1.5-stage procedure due to being clinically unfit for reimplantation. Four patients (11.1%) underwent a 2nd-stage but developed reinfection requiring septic revision. Two patients (5.6%) had failed 1st-stage and underwent Girdlestone procedure. Reinfection rate was 11.1%, all culture-positive at the 2nd-stage. Spacer-related complications occurred in 2/36 (5.6%), including one dislocation (2.8%) and one spacer fracture (2.8%). Revision for dislocation after the 2nd-stage was required in 3/36 (8.3%). Patients with successful reimplantation were younger (P <0.001). Most common microorganisms were Cutibacterium spp. (28.8%) and coagulase-negative Staphylococci (26.9%).
Conclusions: Two-stage septic revision using the DAA shows reinfection-rates comparable to other approaches, with low rates of spacer dislocation and postoperative dislocation after reimplantation.